12 05 2016

BTG plc. to acquire Galil Medical for $110 Million

Galil Medical has agreed to be acquired by BTG plc. Willkie represented certain shareholders in connection with the proposed transaction valued at up to $110 million.


Galil Medical delivers innovative cryoablation solutions. The company is addressing patient conditions across multiple physician specialties including conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. Its offices are located in Minnesota and Israel. Galil’s shareholders include Thomas, McNerney & Partners, The Vertical Group and Investor Growth Capital. UK-based BTG is a growing international specialist healthcare company with a portfolio of interventional medicine products to advance the treatment of liver tumors, advanced emphysema, severe blood clots and varicose veins, and specialty pharmaceuticals that help patients overexposed to certain medications or toxins. The deal was handled by partners Gordon Caplan (Picture), Sean Ewen and Hillel Jacobson; and law clerk Hugh McLaughlin.  Involved fees earner: Gordon Caplan - Willkie Farr & Gallagher; Sean Ewen - Willkie Farr & Gallagher; Hillel Jacobson - Willkie Farr & Gallagher;

LATEST ISSUE
Powered by Share Trading

POPULAR ARTICLES
LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION

09/05/2018

LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION Read about le

LE FONTI AWARDS 2018 CELEBRATES CORPORATE EXCELLENCES IN HONG KONG

29/03/2018

On March 23rd 2018, the world’s leading corporate stars reunited for a special

LE FONTI AWARDS 2017 CELEBRATES CORPORATE EXCELLENCES IN DUBAI

14/12/2017

On December 14th, 2017, the world’s leading corporate stars reunited for a spec

LE FONTI AWARDS 2017 CELEBRATE CORPORATE EXCELLENCES IN LONDON

23/10/2017

On October 20th, 2017, the world’s leading corporate stars reunited for a speci

Le Fonti IAIR Awards Take Hong Kong By Storm

21/03/2017

Hong Kong has become a city of bright expansion, culture, and futuristic innovation. Fr